Eyenovia's Stock Is Soaring Today - Here's Why
William Blair initiated coverage on Eyenovia Inc EYEN, a biopharma company focused on developing therapies based on its Optejet device, which leverages a microdose array print (MAP) technology that allows consistent, reproducible dosing of ophthalmic drugs. Analysts Tim Lugo, Lachlan…#williamblair #eyenoviainceyen #optejet #map #timlugo #lachlanhanburybrown #johnboyle #npv #mydcombi #eyenovia (Source: Reuters: Health)
Source: Reuters: Health - November 1, 2023 Category: Consumer Health News Source Type: news
Cardinal Health, Inc. Issues Voluntary Nationwide Recall of Certain LEADER ™ Brand Eye Drops Supplied by Velocity Pharma, LLC Due to Potential Risk of Eye Infections
Dublin, OH, Cardinal Health, Inc. is initiating a voluntarily recall for all lots of ophthalmic products supplied by Velocity Pharma, LLC to the consumer level. Cardinal Health, Inc. received information from FDA indicating investigators found insanitary conditions in the manufacturing facility and (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 1, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
MD Contests Mandatory Cognitive Tests for Older Docs MD Contests Mandatory Cognitive Tests for Older Docs
An ophthalmologist claims Michigan health system committed age discrimination in a new lawsuit.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 1, 2023 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news
FDA eye drop recall: Don ’t use these CVS, Rite Aid, Walmart and Target brands
The FDA is warning consumers to immediately stop using 27 over-the-counter eye drop products due to the potential risk of eye infections that could result in partial vision loss or blindness. This new eye drop recall follows recalls earlier this year. The over-the-counter lubricating drops are…#fda #cvs #riteaid #garydnovack #ucdavishealth #novack #lubricating #jeffreyhma #ucdaviseyecenter #infections (Source: Reuters: Health)
Source: Reuters: Health - November 1, 2023 Category: Consumer Health News Source Type: news
RevCycle Partners Now Supports MaximEyes.com EHR and Practice Management Software
The revenue cycle management company extends its insurance billing support to optometry practices using MaximEyes.com. CHICAGO, Oct. 31, 2023 /PRNewswire/ -- RevCycle Partners, a leading revenue cycle management (RCM) company, is excited to announce its extended support for MaximEyes.com,... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 31, 2023 Category: Pharmaceuticals Tags: LIC PDT Source Type: news
State Driver ’ s License Laws Could Lead to Underdiagnosis of Dementia, According to New Research
It’s uncomfortable to talk about older adults and driving, a fact that many families who’ve worried about a loved one’s dwindling eyesight, reaction time, or cognition behind the wheel are well aware of. The ability to drive isn’t a right, but in many parts of the U.S. it’s become a necessity, the only way to access the world outside the home. When an older adult’s freedom threatens their safety, who gets to make the choice to take a car or license away?
[time-brightcove not-tgx=”true”]
For a long time, the answer has been an unsure combination of the U.S. government, phy...
Source: TIME: Health - October 30, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Source Type: news
FDA Recalls Dozens More Eye Drop Products FDA Recalls Dozens More Eye Drop Products
More than 2 dozen products could cause eye infections or blindness, after bacterial contamination and unsanitary conditions were found at a manufacturing facility, the agency said.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 30, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology News Source Type: news
FDA issues warning for 26 eyedrops due to risk of infection, blindness
Retailers like CVS, Target and Walgreens pulled the eyedrops after federal inspectors discovered “insanitary conditions” at the manufacturing plant. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - October 30, 2023 Category: Consumer Health News Authors: Julian Mark Source Type: news
Eyedrops from CVS, Rite Aid and others carry possible infection risk, FDA says
U.S. health regulators are warning consumers not to use more than two dozen varieties of over-the-counter eyedrops due to the risk of infections that could lead to blindness (Source: ABC News: Health)
Source: ABC News: Health - October 30, 2023 Category: Consumer Health News Tags: Health Source Type: news
Approach to the diagnosis and management of snakebite envenomation in South Africa in humans: special patient groups and surgical aspects - Hardcastle T, Engelbrecht A, Lalloo V, Bell C, Toubkin M, Motara F, Kajee M.
This article explores the management of snakebite to vulnerable patient groups, namely children and pregnant women as well as providing detail on the current best practice when caring for venom ophthalmia and surgical wounds resulting from snakebite. Final... (Source: SafetyLit)
Source: SafetyLit - October 30, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Eyedrops From Major Brands May Cause Infection, F.D.A. Says
Target, CVS and Rite Aid are pulling products from shelves after federal investigators found unsanitary conditions and recommended a recall. (Source: NYT Health)
Source: NYT Health - October 29, 2023 Category: Consumer Health News Authors: Rebecca Carballo Tags: Eyes and Eyesight Drugs (Pharmaceuticals) Infections Regulation and Deregulation of Industry Food and Drug Administration United States Source Type: news
Staring at Screens Can Cause Eye Strain. Here's Tips to Prevent That
SATURDAY, Oct. 28, 2023 -- Millions of people spend hours looking at screens every day, straining their eyes.An ophthalmologist at Baylor College of Medicine in Houston offers some tips for easing both eye strain and headaches. “We focus on one... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 28, 2023 Category: General Medicine Source Type: news
AAO 2023: New Modes of Treatments and New Directions for Diabetic Macular Edema AAO 2023: New Modes of Treatments and New Directions for Diabetic Macular Edema
Dr Sunir Garg outlines several topics to be addressed at AAO 2023, including enhancements to anti-VEGF therapy and strategies for making clinical trials more representative of the general population.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 27, 2023 Category: Consumer Health News Tags: Ophthalmology MDAngle Source Type: news
AAO 2023: Anticipating New and Real-World Data in AMD AAO 2023: Anticipating New and Real-World Data in AMD
Dr Vaidehi Dedania looks ahead to the 2023 AAO meeting expecting updates from trials on geographic atrophy as well as clinical best-practices regarding therapies for exudative macular degeneration.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 27, 2023 Category: Consumer Health News Tags: Ophthalmology MDAngle Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] FDA approves Roche ’s Vabysmo for the treatment of retinal vein occlusion (RVO)
RVO is the third indication for Vabysmo, in addition to neovascular or ‘wet’ age-related macular degeneration and diabetic macular edemaApproval is based on two phase III studies demonstrating early and sustained vision improvements that were non-inferior to afliberceptVabysmo also demonstrated rapid and robust drying of retinal fluidAdditional U.S. label update across indications includes information on rare post-marketing reports of retinal vasculitis and/or retinal vascular occlusion; reporting rate isin line withother broadly used intravitreal treatmentsBasel, 27 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) an...
Source: Roche Investor Update - October 27, 2023 Category: Pharmaceuticals Source Type: news
